Trial intelligence / Profile preview

Topiramate for treatment of amphetamine and methamphetamine dependence

IRCT20160417027437N2Phase 3Completed

Sponsor
Ahvaz Jundishapur University of Medical Sciences
Start
Jul 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of topiramate in amphetamine dependence, methamphetamine use disorder (MUD) and stimulant use disorder (SUD), sponsored by Ahvaz Jundishapur University of Medical Sciences. Started Jul 2021; status: completed.

02

Drugs

topiramate
03

Conditions

amphetamine dependencemethamphetamine use disorder (MUD)stimulant use disorder (SUD)

Beyond the preview

Go deeper on IRCT20160417027437N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20160417027437N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call